4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000244
EVP CLO & General Counsel sold 64,664 shares at $67.69 ($4,377,054)
- EVP CLO & General Counsel acquired 64,664 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
O'NEIL PATRICK R. · EVP CLO & General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +30,203 | $56.78 | $1,714,926 | 87,333 | D |
| 2025-10-02 | Sale : show line 2 in the form 10b5-1 | −30,203 | $67.69 | $2,044,417 | 57,130 | D |
| 2025-10-02 | Exercise or conversion : show line 3 in the form 10b5-1 | +34,461 | $60.89 | $2,098,330 | 91,591 | D |
| 2025-10-02 | Sale : show line 4 in the form 10b5-1 | −34,461 | $67.69 | $2,332,638 | 57,130 | D |
| Open-market sales · 64,664 sh · avg $67.69 · $4,377,054 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-10-02 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −30,203 | 0 | D |
| 2025-10-02 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −34,461 | 0 | D |
Loading xslF345X05/edgardoc.xml…